BAX Baxter International Inc
Price (delayed)
$33.82
Market cap
$17.3B
P/E Ratio
N/A
Dividend/share
$1.04
EPS
-$1.27
Enterprise value
$28.91B
Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, it has been operating
Highlights
Baxter International's debt has decreased by 4.7% YoY
The quick ratio is down by 28% year-on-year but it is up by 3.9% since the previous quarter
The revenue is down by 17% since the previous quarter but it is up by 2.7% year-on-year
BAX's net income has dropped by 124% year-on-year
The EPS has plunged by 124% YoY
Key stats
What are the main financial stats of BAX
Market
Valuations
Earnings
Shares outstanding
511.62M
Market cap
$17.3B
Enterprise value
$28.91B
Price to earnings (P/E)
N/A
Price to book (P/B)
2.48
Price to sales (P/S)
1.62
EV/EBIT
N/A
EV/EBITDA
39.82
EV/Sales
2.72
Revenue
$10.64B
Gross profit
$3.98B
Operating income
$14M
Net income
-$649M
EBIT
-$271M
EBITDA
$726M
Free cash flow
$559M
Per share
Balance sheet
Liquidity
EPS
-$1.27
EPS diluted
-$1.27
Free cash flow per share
$1.1
Book value per share
$13.64
Revenue per share
$20.85
TBVPS
$29.97
Total assets
$25.78B
Total liabilities
$18.76B
Debt
$13.37B
Equity
$6.96B
Working capital
$2.34B
Debt to equity
1.92
Current ratio
1.36
Quick ratio
0.53
Net debt/EBITDA
15.98
Margins
Efficiency
Dividend
EBITDA margin
6.8%
Gross margin
37.5%
Net margin
-6.1%
Operating margin
0.1%
Return on assets
-2.4%
Return on equity
-8.5%
Return on invested capital
-1.3%
Return on capital employed
-1.4%
Return on sales
-2.5%
Dividend yield
3.08%
DPS
$1.04
Payout ratio
495.2%
BAX stock price
How has the Baxter International stock price performed over time
Intraday
1.14%
1 week
9.73%
1 month
7.43%
1 year
-19.91%
YTD
15.98%
QTD
15.98%
Financial performance
How have Baxter International's revenue and profit performed over time
Revenue
$10.64B
Gross profit
$3.98B
Operating income
$14M
Net income
-$649M
Gross margin
37.5%
Net margin
-6.1%
BAX's net income has dropped by 124% year-on-year
Baxter International's net margin has plunged by 124% YoY
The operating margin has plunged by 99% YoY and by 97% from the previous quarter
Baxter International's operating income has plunged by 98% YoY and by 97% from the previous quarter
Growth
What is Baxter International's growth rate over time
Valuation
What is Baxter International stock price valuation
P/E
N/A
P/B
2.48
P/S
1.62
EV/EBIT
N/A
EV/EBITDA
39.82
EV/Sales
2.72
The EPS has plunged by 124% YoY
BAX's P/B is 36% below its 5-year quarterly average of 3.9 but 3.3% above its last 4 quarters average of 2.4
The company's equity fell by 17% YoY and by 12% QoQ
BAX's P/S is 38% below its 5-year quarterly average of 2.6 but 8% above its last 4 quarters average of 1.5
The revenue is down by 17% since the previous quarter but it is up by 2.7% year-on-year
Efficiency
How efficient is Baxter International business performance
The ROS has plunged by 156% from the previous quarter and by 108% YoY
The ROIC has plunged by 146% from the previous quarter and by 110% YoY
The ROA has plunged by 126% YoY
The company's return on equity has shrunk by 122% YoY
Dividends
What is BAX's dividend history
DPS
$1.04
Dividend yield
3.08%
Payout ratio
495.2%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Baxter International financials performed over time
The total assets is 37% more than the total liabilities
The quick ratio is down by 28% year-on-year but it is up by 3.9% since the previous quarter
The total assets has contracted by 9% YoY and by 3.4% from the previous quarter
Baxter International's debt is 92% more than its equity
The company's equity fell by 17% YoY and by 12% QoQ
The debt to equity has increased by 15% year-on-year and by 14% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.